Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subanesthetic ketamine for perioperative symptoms and recovery in radical mastectomy
ChiCTR2100048544Phase 4Recruiting
- Sponsor
- Anhui Provincial Tumor Hospital
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ketamine in breast cancer, postoperative pain, anxiety disorder and 1 more (2 arms), sponsored by Anhui Provincial Tumor Hospital. Primary endpoints: Perioperative anesthetic dosage, Visual Analogue Scale score and 4 more. Started Jul 2021; status: recruiting.
02
Drugs
ketamine
03
Conditions
breast cancerpostoperative painanxiety disordermajor depressive disorder (MDD)
Beyond the preview
Go deeper on ChiCTR2100048544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100048544.